Freestone Grove Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.58M Buy
+20,088
New +$3.28M 0.03% 322

Other funds holding GH

Freestone Grove Partners's GH Position: Q3 2026 in Review

Freestone Grove Partners opened a new position in Guardant Health (GH) in Q3 2026: 20,088 shares worth $3.58M. The stake represents 0.03% of the portfolio and ranks #322 among its holdings.

673 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Freestone Grove Partners held 20,088 shares of Guardant Health worth $3.58M as of Q3 2026.
  • Guardant Health was a new Freestone Grove Partners position in Q3 2026.
  • Guardant Health made up 0.03% of Freestone Grove Partners's portfolio in Q3 2026, its #322 holding.
  • 673 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Freestone Grove Partners's 13F filing for Q3 2026, filed 16 Nov 2026.